25 May 2011

UCB to conduct first anti-TNF head-to-head study between Cimzia® (certolizumab pegol) and Humira®* (adalimumab)

Read More
19 May 2011

Acquisition of own shares by UCB SA/NV

Read More
17 May 2011

Call for Entries: International Bureau for Epilepsy and UCB launch the 2011 Excellence in Epilepsy Journalism Award to recognise outstanding reporting on epilepsy

Read More
16 May 2011

Baxter, UCB, TRI-VIZOR and H.Essers announce world’s first example of “orchestrated carpooling for cargo”

Read More
16 May 2011

Novel ACR hybrid score in rheumatoid arthritis applied for the first time to data from the RAPID 1 study with Cimzia® (certolizumab pegol)

Read More
12 May 2011

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
9 May 2011

Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients

Read More
9 May 2011

UCL – UCB Chair: UCL develops research on lupus and arthritis with the support of UCB

Read More
5 May 2011

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
5 May 2011

Transparency notification of Schwarz Vermögensverwaltung GmbH & Co, Financière de Tubize SA and UCB SA/NV

Read More
Subscribe to